Virtual Care for Cardiometabolic Diseases: Opportunities for Pharma

Cardiometabolic diseases are a leading cause of death globally, these conditions span from heart failure, stroke, type2 diabetes, hypertension and many others. Better patient outcomes are emerging with the use of Virtual Care programs, therefore there seems to be a huge opportunity for Pharma to work in tandem with Virtual Care companies in order to drive better health outcomes for their patients. But the business model for Pharma is still not clear.